MUSAZZI LAURA

Role
Associate professor  
Academic disciplines
Pharmacology (BIOS-11/A)
Scientific-Disciplinary Group:
PHARMACOLOGY (05/BIOS-11)
Office phone

Publications

  • Mingardi, J., Meanti, R., Paoli, C., Cifani, C., Torsello, A., Popoli, M., et al. (2025). Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What
    Are the Connections?. CURRENT NEUROPHARMACOLOGY, 23(2), 172-186 [10.2174/1570159x22999240722095039].
     Detail

  • Mingardi, J., Musazzi, L. (2025). Glutamatergic Changes Induced by Stress in the Brain and Effects of Rapid-Acting Antidepressants. In C.R. Martin, V.R. Preedy, V.B. Patel, R. Rajendram (a cura di), Handbook of the Biology and Pathology of Mental Disorders (pp. 1-23). Springer Nature [10.1007/978-3-031-32035-4_35-1]. Detail

  • Mingardi, J., Misztak, P., Magri, C., Martini, P., Chinello, C., Pagani, L., et al. (2024). Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression.. Intervento presentato a: 42mo Congresso della Società Italiana di Farmacologia - 13 - 16 novembre 2024, Sorrento, Italia. Detail

  • Derosa, S., Misztak, P., Mingardi, J., Mazzini, G., Müller, H., Musazzi, L. (2024). Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 128(10 January 2024) [10.1016/j.pnpbp.2023.110871]. Detail

  • Nicosia, N., Giovenzana, M., Misztak, P., Mingardi, J., Musazzi, L. (2024). Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(12) [10.3390/ijms25126521]. Detail

Research projects

GEEKS - Evaluation of Gene-Environment interaction and protective Effects of Ketamine in Shank2 and Shank3 mice- PNRR Missione 4 “Istruzione e ricerca” – Componente 2 “Dalla ricerca all’impresa” – Investimento 1.3, Avviso n. 341 del 15.03.2022 PE PE00000006
Year: 2023
Call: A multiscale integrated approach to the study of the nervous system in health and disease
Grantors: Università degli Studi di PARMA
Diseases induced by InflammAtion during DEvelopMent: the Adolescent window of susceptibility and resilience (DIADEMA)
Year: 2021
Call: FAQC 2021 - terza finestra
Grantors: Università degli Studi di MILANO-BICOCCA
DNA Methylation signature of KEtamine Response in the treatment of comorbid depression and anxiety (DNA-MaKER)
Year: 2020
Grantors: FONDAZIONE CARIPLO

Awards

Awards

  • PALADINI ITALIANI DELLA SALUTE, Associazione Liber, 2024
  • Premio Farmindustria-Società italiana di Farmacologia (SIF) giovani ricercatori, Farmindustria-Società italiana di Farmacologia (SIF), 2015
  • Premio SIF per ricerche di farmacologia, area Sistema Nervoso Centrale, bandito grazie al contributo incondizionato di Otsuka Pharmaceutical Italy Srl, 2014

Scientific fellowships

  • Socio effettivo o corrispondente - The International College of Neuropsychopharmacology, 2021
  • Socio effettivo o corrispondente - European College of Neuropsychopharmacology, 2020
  • Socio effettivo o corrispondente - Società Italiana di Neuroscienze, 2016
  • Fellow - European College of Neuropsychopharmacology (ECNP), 2010
  • Socio effettivo o corrispondente - Società Italiana di Farmacologia, 2005

Research and teaching assignments

  • Visiting Researcher - Post-doc visiting scientist - Aarhus Universitet, 2010 - 2011
  • Ricercatore universitario a t.d. - Università degli Studi di MILANO, 2015 - 2018

Congresses/Conferences

  • Revisore - 35th WORLD CONGRESS World Congress Collegium Internationale Neuro-Psychopharmacologicum(Giappone), 2024
  • Program chair - School of Neuroscience: from cellular mechanisms to disease modelling(Italia), 2022